TY  - CHAP
M1  - Book, Section
TI  - Ethical, Legal, and Social Issues in Pharmacogenomics
A1  - Parker, Lisa S.
A2  - Lam, Jerika T.
A2  - Gutierrez, Mary A.
A2  - Shah, Samit
PY  - 2021
T2  - Pharmacogenomics: A Primer for Clinicians
AB  - LEARNING  OBJECTIVESAfter  reading  this  chapter,  readers  will  be  able  to:Explain  the  relevant  ethical,  legal,  and  social  (ELS)  considerations  to  patients/clients  considering  pharmacogenomics  (PGx)  testing.Respond  to  questions  from  the  media  and  public  about  ELS  issues  associated  with  PGx.Participate  in  institutional  or  industry-level  policy  making  about  PGx  in  light  of  ELS  concerns.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/25
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1179509640
ER  -